Prevalence and characteristics of genetic disease in adult kidney stone formersManuel Anderegg, Daniel G. Fuster, Robert Geraghty et al.|Nephrology Dialysis Transplantation|2024Cited by 45
Kidney stone disease: risk factors, pathophysiology and managementMatteo Bargagli, Daniel G. Fuster, Sarah Howles et al.|Nature Reviews Nephrology|2025Cited by 43
Urinary Lithogenic Risk Profile in ADPKD Patients Treated with TolvaptanMatteo Bargagli, Daniel G. Fuster, Pietro Manuel Ferraro et al.|Clinical Journal of the American Society of Nephrology|2020Cited by 34
Empagliflozin in nondiabetic individuals with calcium and uric acid kidney stones: a randomized phase 2 trialManuel Anderegg, Daniel G. Fuster, Lia Bally et al.|Nature Medicine|2025Cited by 25
The Role of Diet in Bone and Mineral Metabolism and Secondary HyperparathyroidismMatteo Bargagli, Pietro Manuel Ferraro, Maria Arena et al.|Nutrients|2021Cited by 24